Weight Loss
RX ONLY
SEMAGLUTIDE
SUBLINGUAL SUSPENSION
- Formulated with a base tailored to semaglutide’s properties
- Bypasses the GI tract, preserving medication bioavailability
- Made with USP-grade ingredients from FDA-registered suppliers
Carie Boyd offers sublingual semaglutide as a convenient, non-injectable option to support weight management. It is supplied in 30 mL vials at two concentrations:
1 mg/mL and 2 mg/mL.
This medication requires a patient prescription.
Our semaglutide suspension is compounded exclusively with commercially available Rybelsus®, which is an FDA-approved tablet. The sublingual route of administration bypasses the gastrointestinal tract, preserving medication bioavailability. This innovative dosage form offers convenience and may improve adherence in weight management.
We use a base tailored to semaglutide’s molecular weight and properties. The emulsion behavior in saliva enhances solubility and dispersion. Its permeation-enhancing effect works through mucoadhesion, increasing contact time with the sublingual mucosa.
Sublingual semaglutide suspension is available in two strengths, each supplied in a 30 mL vial:
- 1mg/mL
- 2mg/mL
Begin with a daily sublingual dose of 1 mg for 2-3 weeks, then gradually increase up to 1.5 mg daily, as needed.
Hints of smooth mint provide a pleasant flavor to the suspension.
- The medication should be stored at room temperature and protected from direct light.
- Beyond-Use-Dating: 90 Days.
- We ship to all 50 states, Monday through Friday.
- Overnight service is available.
- This medication can be delivered to the patient or to the prescriber’s office.
With a vetted API supplier, scientifically engineered base, and pleasant flavor, providers can confidently tailor semaglutide sublingual suspension to support patient weight loss goals. This innovative, non-invasive dosage form can enhance compliance by offering a seamless alternative to injections.
At Carie Boyd Pharmaceuticals, healthcare providers can submit a prescription, and patients can refill a prescription online. Prescription medications are not sold directly to patients; it can only be done through a qualified healthcare provider. We ship patient-specific medications to every state and Puerto Rico.
PRESCRIBER INFORMATION
Our suspension is
compounded exclusively with
Rybelsus®, an FDA-approved
tablet. This commitment to
transparent and responsibly-sourced
ingredients helps us
maintain our devotion to
Compounding with Integrity.
The base used in our
suspension is engineered to
handle molecules like
semaglutide for sublingual
administration. This
anhydrous base allows for a
beyond-use date of 90 days
at room temperature.
The emulsion behavior in the saliva
enhances solubility and dispersion.
Its permeation-enhancing effect
works through mucoadhesion, increasing
contact time with the sublingual mucosa.
Brush teeth before administration and
rinse with warm water, shake the vial well,
and administer the dose. Hold under
the tongue for 2 minutes then swallow.
Do not eat or drink for 30 minutes.
PCCA consultants have reported
no instances of GI effects
requiring dose reduction or discontinuation
with a daily 1.5 mg sublingual dose.
They have also observed consistent
weight loss of 1-2 pounds per week.
Careful evaluation and monitoring
of side effects is suggested for dosing
beyond 1.5 mg. Monitoring parameters
and potential side effects for patients
starting semaglutide are the
same for any dosage form.
Pharmacists are available for consultation
Fax: (940) 382-2694
Phone: 940-382-6758 | Speak to a pharmacist